Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: comparison with CT in a prospective multicenter study.
Kwee TC, Vermoolen MA, Akkerman EA, Kersten MJ, Fijnheer R, Ludwig I, Beek FJ, van Leeuwen MS, Bierings MB, Bruin MC, Zsíros J, Quarles van Ufford HM, de Klerk JM, Adam J, Stoker J, Uiterwaal CS, Nievelstein RA. Kwee TC, et al. Among authors: kersten mj. J Magn Reson Imaging. 2014 Jul;40(1):26-36. doi: 10.1002/jmri.24356. Epub 2013 Oct 31. J Magn Reson Imaging. 2014. PMID: 24307538
Magnetic resonance imaging of malignant lymphoma.
Vermoolen MA, Kersten MJ, Fijnheer R, van Leeuwen MS, Kwee TC, Nievelstein RA. Vermoolen MA, et al. Among authors: kersten mj. Expert Rev Hematol. 2011 Apr;4(2):161-71. doi: 10.1586/ehm.11.17. Expert Rev Hematol. 2011. PMID: 21495926 Review.
MRI for staging lymphoma: whole-body or less?
Kwee TC, Akkerman EM, Fijnheer R, Kersten MJ, Zsíros J, Ludwig I, Bierings MB, Vermoolen MA, van Leeuwen MS, Stoker J, Nievelstein RA. Kwee TC, et al. Among authors: kersten mj. J Magn Reson Imaging. 2011 May;33(5):1144-50. doi: 10.1002/jmri.22549. J Magn Reson Imaging. 2011. PMID: 21509873
Relationship between pretreatment FDG-PET and diffusion-weighted MRI biomarkers in diffuse large B-cell lymphoma.
de Jong A, Kwee TC, de Klerk JM, Adam JA, de Keizer B, Fijnheer R, Kersten MJ, Ludwig I, Jauw YW, Zijlstra JM, Pieters-Van den Bos IC, Stoker J, Hoekstra OS, Nievelstein RA. de Jong A, et al. Among authors: kersten mj. Am J Nucl Med Mol Imaging. 2014 Apr 25;4(3):231-8. eCollection 2014. Am J Nucl Med Mol Imaging. 2014. PMID: 24795837 Free PMC article.
Computed Tomography Observer Agreement in Staging Malignant Lymphoma.
de Jong A, Kwee TC, Quarles van Ufford HM, Beek FJ, Quekel LG, de Klerk JM, Zijlstra JM, Fijnheer R, Ludwig I, Kersten MJ, Stoker J, Nievelstein RA. de Jong A, et al. Among authors: kersten mj. J Comput Assist Tomogr. 2016 Mar-Apr;40(2):261-5. doi: 10.1097/RCT.0000000000000338. J Comput Assist Tomogr. 2016. PMID: 26599962
HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma.
Stevens WBC, Bakunina K, Cuijpers M, Chamuleau M, Beeker A, Fijnheer R, Hebart H, Visser HPJ, Doorduijn JK, Linton K, Dreyling M, de Jong D, Kersten MJ. Stevens WBC, et al. Among authors: kersten mj. Hemasphere. 2020 Jan 3;4(1):e325. doi: 10.1097/HS9.0000000000000325. eCollection 2020 Feb. Hemasphere. 2020. PMID: 32072141 Free PMC article.
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Chamuleau MED, Burggraaff CN, Nijland M, Bakunina K, Mous R, Lugtenburg PJ, Dierickx D, van Imhoff GW, Vermaat JSP, Marijt EAF, Visser O, Mandigers C, Bilgin YM, Beeker A, Durian MF, van Rees B, Bohmer LH, Tick LW, Boersma RS, Snijders TJF, Schouten HC, Koene HR, de Jongh E, Hijmering N, Diepstra A, van den Berg A, Arens AIJ, Huijbregts J, Hoekstra O, Zijlstra JM, de Jong D, Kersten MJ. Chamuleau MED, et al. Among authors: kersten mj. Haematologica. 2020 Dec 1;105(12):2805-2812. doi: 10.3324/haematol.2019.238162. Haematologica. 2020. PMID: 33256379 Free PMC article. Clinical Trial.
278 results